| Literature DB >> 30291260 |
Xianzhi Ma1, Shengshou Han1, Jun Ma1, Xiaotao Chen1, Wenbin Bai1, Wenqi Yan1, Kai Wang2.
Abstract
The study aimed to explore the epidemiology and clinical characteristics of chronic osteomyelitis observed in a northern China hospital. Clinical data of 255 patients with chronic osteomyelitis from January 2007 to January 2014 were collected and analyzed, including general information, disease data, treatment and follow-up data. Chronic osteomyelitis is more common in males and in the age group from 41-50 years of age. Common infection sites are the femur, tibiofibular, and hip joint. More g+ than g- bacterial infections were observed, with S. aureus the most commonly observed pathogenic organism. The positive detection rate from debridement bacterial culture is 75.6%. The detection rate when five samples are sent for bacterial culture is 90.6%, with pathogenic bacteria identified in 82.8% of cases. The two-stage debridement method (87.0%) has higher first curative rate than the one-stage debridement method (71.2%). To improve detection rate using bacterial culture, at least five samples are recommended. Treatment of chronic osteomyelitis with two-stage debridement, plus antibiotic-loaded polymethylmethacrylate (PMMA) beads provided good clinical results in this study and is therefore recommended.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30291260 PMCID: PMC6173749 DOI: 10.1038/s41598-018-33106-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Cierny-Mader classification results.
| Host A | Host BL | Host BS | Host BL+BS | Host C | ||
|---|---|---|---|---|---|---|
| Type I | Cases | 10 | 2 | 1 | 0 | 0 |
| Percentage | 3.9% | 0.8% | 0.4% | 0.0% | 0.0% | |
| Type II | Cases | 59 | 13 | 17 | 8 | 0 |
| Percentage | 23.1% | 5.1% | 6.7% | 3.1% | 0.0% | |
| Type III | Cases | 52 | 10 | 8 | 5 | 0 |
| Percentage | 20.4% | 3.9% | 3.1% | 2.0% | 0.0% | |
| Type VI | Cases | 46 | 17 | 4 | 3 | 0 |
| Percentage | 18.0% | 6.7% | 1.6% | 1.2% | 0.0% |
Laboratory tests of WBC, ESR and CRP.
| Frequency | Percentage | |
|---|---|---|
| WBC(+) | 104 | 32.2% |
| WBC(−) | 219 | 67.8% |
| ESR(+) | 230 | 71.2% |
| ESR(−) | 93 | 28.8% |
| CRP(+) | 290 | 89.7% |
| CRP(−) | 83 | 10.3% |
Comprehensive statistics of WBC, ESR and CRP.
| WBC | ESR | CRP | Times | Percentage | |
|---|---|---|---|---|---|
| Result 1 | (−) | (−) | (−) | 20 | 6.6% |
| Result 2 | (+) | (−) | (−) | 3 | 1.0% |
| Result 3 | (−) | (+) | (−) | 2 | 0.7% |
| Result 4 | (−) | (−) | (+) | 53 | 17.4% |
| Result 5 | (+) | (+) | (−) | 0 | 0.0% |
| Result 6 | (+) | (−) | (+) | 8 | 2.6% |
| Result 7 | (−) | (+) | (+) | 132 | 43.4% |
| Result 8 | (+) | (+) | (+) | 86 | 28.3% |
| In total | 304 | 100.0% |
Bacterial distribution.
| Bacterial | Frequency | Percentage |
|---|---|---|
| Staphylococcus aureus | 87 | 35.51% |
| Staphylococcus epidermidis | 35 | 14.29% |
| Pseudomonas aeruginosa | 24 | 9.80% |
| Enterobacter cloacae | 13 | 5.31% |
| Escherichia coli | 11 | 4.49% |
| Klebsiella pneumoniae | 7 | 2.86% |
| Staphylococcus capitis | 6 | 2.45% |
| Baumann’s acinetobacter complex. | 6 | 2.45% |
| Enterococcus faecalis | 5 | 2.04% |
| Staphylococcus haemolyticus | 4 | 1.63% |
| Enterococcus faecium | 4 | 1.63% |
| Staphylococcus hominis | 4 | 1.63% |
| Serratia marcescens | 4 | 1.63% |
| Others | 14.28% |
Detection rate when using different numbers of samples, and the correlations between detection rate and number of samples.
| Number of samples for detection | Detection times | Negative result | Positive result | Detection rate | Compare with other groups | P Value |
|---|---|---|---|---|---|---|
| 1 sample | 63 | 21 | 42 | 66.7% | VS 2 sample | >0.05 |
| VS 3 samples | >0.05 | |||||
| VS 4 samples | >0.05 | |||||
| VS 5 samples | <0.05 | |||||
| 2 samples | 76 | 23 | 53 | 69.7% | VS 3 samples | >0.05 |
| VS 4 samples | >0.05 | |||||
| VS 5 samples | <0.05 | |||||
| 3 samples | 51 | 13 | 38 | 74.5% | VS 4 samples | >0.05 |
| VS 5 samples | <0.05 | |||||
| 4 samples | 41 | 9 | 32 | 78.0% | VS 5 samples | >0.05 |
| 5 samples or above | 64 | 6 | 58 | 90.6% |
Ability to identify pathogenic bacteria for different numbers of sample, and the correlation between number of samples and identification success.
| Sample | Times of detection | Identifying pathogenic bacteria | Fail to identify pathogenic bacteria | Percentage of identifying pathogenic bacteria |
|---|---|---|---|---|
| 2 samples | 76 | 32 | 44 | 42.1% |
| 3 samples | 52 | 27 | 25 | 51.9% |
| 4 samples | 41 | 28 | 13 | 68.3% |
| 5 samples and above | 64 | 53 | 11 | 82.8% |
|
| ||||
| 2 samples VS 3 samples | >0.05 | |||
| 2 samples VS 4 samples | <0.05 | |||
| 2 samples VS 5 samples | <0.05 | |||
| 3 samples VS 4 samples | >0.05 | |||
| 3 samples VS 5 samples | <0.05 | |||
| 4 samples VS 5 samples | >0.05 | |||
The distribution of bacteria found in the sinus tract.
| Bacteria | Frequency | Percentage |
|---|---|---|
| staphylococcus aureus | 15 | 25.86% |
| staphylococcus epidermidis | 9 | 15.52% |
| pseudomonas aeruginosa | 5 | 8.62% |
| enterobacter cloacae | 3 | 5.17% |
| escherichia coli | 3 | 5.17% |
| staphylococcus haemolyticus | 2 | 3.45% |
| enterococcus faecalis | 2 | 3.45% |
| klebsiella pneumoniae | 2 | 3.45% |
| Baumann’s acinetobacter complex. | 2 | 3.45% |
| Candida albicans | 2 | 3.45% |
| Rhodococcus rhodococcus | 2 | 3.45% |
| peptostreptococcus anaerobius | 2 | 3.45% |
| staphylococcus warneri | 1 | 1.72% |
| Enterobacter agglomerans | 1 | 1.72% |
| enterobacter | 1 | 1.72% |
| providencia rettgeri | 1 | 1.72% |
| staphylococcus hominis | 1 | 1.72% |
| citrobacter braakii | 1 | 1.72% |
| staphylococcus saprophyticus | 1 | 1.72% |
| proteus mirabilis | 1 | 1.72% |
| klebsiella oxytoca | 1 | 1.72% |
| In total | 58 | 100.0% |
Clinical effects and prognosis of the two different treatments.
| Treatment | Two-stage (108cases) | One-stage (147cases) | P-value |
|---|---|---|---|
| union | 94 | 105 | <0.05 |
| Recurrence | 14 | 42 | <0.05 |
| Union rate after first treatment | 87.0% | 71.4% | <0.05 |
| Continue the treatment after Recurrence | 11 | 30 | >0.05 |
| Union after once retreatment | 9 | 4 | <0.05 |
| Union after twice retreatments | 0 | 13 | — |
| Union after thrice treatments | 0 | 12 | — |
| Withdraw treatment after Recurrence | 3 | 6 | >0.05 |
| Nonunion(amputation) | 2 | 1 | >0.05 |